Ownership history in Diametric Capital, LP · 7 quarters on record
This page tracks every 13F SEC filing in which Diametric Capital, LP reported a position in DAY ONE BIOPHARMACEUTICALS I (DAWN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 38,465 | -11,476 | -23.0% | 0.10% | $271K | $7.05 |
| 2025 Q2 | ADDED | 49,941 | +25,465 | +104.0% | 0.17% | $325K | $6.50 |
| 2025 Q1 | ADDED | 24,476 | +13,748 | +128.2% | 0.23% | $194K | $7.93 |
| 2024 Q4 | REDUCED | 10,728 | -6,995 | -39.5% | 0.09% | $136K | $12.67 |
| 2024 Q3 | ADDED | 17,723 | +2,700 | +18.0% | 0.12% | $247K | $13.93 |
| 2024 Q2 | REDUCED | 15,023 | -3,773 | -20.1% | 0.11% | $207K | $13.78 |
| 2024 Q1 | INITIATED | 18,796 | — | — | 0.17% | $311K | — |
As of 2025 Q4 — sorted by position size